Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov page, linking to updates about a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:30:04.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:19:21.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-10T16:19:22.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error in place of the study details, replacing the trial content and navigation with a generic error message. This indicates that access to the record is blocked on this URL.
    Difference
    18%
    Check dated 2026-09-19T19:21:37.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating a minor version update. This change does not alter the study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:35:48.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a new build. This change is metadata-level and does not alter the study details or other visible content.
    Difference
    0.1%
    Check dated 2026-08-08T19:59:15.000Z thumbnail image

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.